News Conference News THT 2026 AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear Todd Neale March 10, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
Presentation THT 2026 Effect of RV Function on Prognosis in HF and Valvular Heart Disease Presenter: Kashish Goel March 04, 2026
Presentation THT 2026 RV Response in Valvular Heart Disease Presenter: Michael I. Brener March 04, 2026
Presentation THT 2026 Real-World Utilization Patterns of Disease-Modifying Therapies in Transthyretin Amyloidosis: An EPIC Cosmos database study Presenter: Arvind Bhimaraj March 03, 2026
Presentation THT 2026 Debate: A Patient With MR Not Improving With GDMT: Go to VAD Presenter: Jaya Batra March 03, 2026
Presentation THT 2026 Debate: A Patient With MR Not Improving With GDMT: Try mTEER Presenter: Karl-Philipp Rommel March 03, 2026
Presentation THT 2026 Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis Presenter: Nicolas M. Van Mieghem March 03, 2026
Presentation THT 2026 Exercise-Induced MR: Implications for Diagnosis and Treatment Presenter: Nikhil Narang March 03, 2026
Presentation THT 2026 Anatomic Considerations for T-TEER and TTVR Presenter: Jörg Hausleiter March 03, 2026
Presentation THT 2026 An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients Presenter: Michael I. Brener March 03, 2026
Presentation THT 2026 Jena-VAD Trial Updates and Lessons Learned Presenter: Gabriel Sayer March 03, 2026
Presentation THT 2026 Case Presentation of LVAD-AR JenaValve Implantation (Prerecorded Live Case) Presenter: Torsten P. Vahl March 03, 2026
Presentation THT 2026 Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis Presenter: Hanna Gaggin March 03, 2026
Presentation THT 2026 Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study Presenter: Ryan J. Tedford March 03, 2026
Presentation THT 2026 Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future Presenter: Eric D. Adler March 02, 2026
Presentation THT 2026 AHF is an Opportunity To Improve CV Care — Arrhythmias, Ischemia, Valvular Heart Disease Presenter: Marat Fudim March 02, 2026